Karen L. Daniel - 19 Nov 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol
TDOC
Transactions as of
19 Nov 2021
Net transactions value
-$12,571
Form type
4
Filing time
23 Nov 2021, 15:12:38 UTC
Previous filing
21 Nov 2022
Next filing
02 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +436 +1% 42,351 19 Nov 2021 Direct F1
transaction TDOC Common Stock Sale $12,571 -109 -0.26% $115.33 42,242 22 Nov 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -436 -33% $0.000000 872 19 Nov 2021 Common Stock 436 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 This sale was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 14, 2021.
F3 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4 The restricted stock unit vests in three substantially equal annual installments beginning November 19, 2021.